The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Mark Bertolini, formerly the CEO of Aetna (CVS), says narrow networks and lower cost options in the ACA marketplace are better for individuals, but that Aetna's exit isn't good for the market. Still, ...